Related Experiment Video
Updated: Jan 26, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Favorable response to apremilast in a patient with refractory psoriasis verrucosa
Sari Okazaki1, Risa Osawa1, Hideki Nakajima1
1Department of Dermatology, Kochi Medical School, Kochi University, Nankoku, Japan.
Abstract:
A 67-year-old man, who had been diagnosed with psoriasis 30 years prior, visited our hospital with a complaint of verrucous nodules in the lower legs, which had developed 15 years previously. We diagnosed him as having psoriasis verrucosa of the legs and plaque psoriasis of the torso. Because the lesions were resistant to topical glucocorticoids and vitamin D3 , a verrucous lesion in the right leg was treated with surgical ablation, which resulted in the development of generalized pustular psoriasis. After pustular lesions were cleared by systemic glucocorticoids and methotrexate, we treated him with etretinate and cyclosporin, but the verrucous lesions accompanied by chronic bacterial infection persisted over time. One year ago, treatment with recently-approved apremilast was started. It immediately attenuated the plaques and erythropapular lesions of the trunk. Surprisingly, the verrucous nodules of both legs showed reduction in size in 2 months.
Related Concept Videos
Gibbs Free Energy and Thermodynamic Favorability
Responses to Gravity and Touch
Humoral Immune Responses
Responses to Drought and Flooding
Responses to Salt Stress
Responses to Heat and Cold Stress

